| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3353010
Max Phase: Preclinical
Molecular Formula: C16H21N5O
Molecular Weight: 299.38
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: OC[C@]12CC[C@H](C1)[C@H](n1cnc3c(NC4CC4)ncnc31)C2
Standard InChI: InChI=1S/C16H21N5O/c22-7-16-4-3-10(5-16)12(6-16)21-9-19-13-14(20-11-1-2-11)17-8-18-15(13)21/h8-12,22H,1-7H2,(H,17,18,20)/t10-,12-,16-/m1/s1
Standard InChI Key: ZWYRKODAWPMOAL-NSODJVPESA-N
Associated Targets(non-human)
Coxsackievirus B4 2249 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 299.38 | Molecular Weight (Monoisotopic): 299.1746 | AlogP: 2.12 | #Rotatable Bonds: 4 |
| Polar Surface Area: 75.86 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 3.55 | CX LogP: 1.02 | CX LogD: 1.02 |
| Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.90 | Np Likeness Score: 0.10 |
References
| 1. Dejmek M, Šála M, Hřebabecký H, Dračínský M, Procházková E, Chalupská D, Klíma M, Plačková P, Hájek M, Andrei G, Naesens L, Leyssen P, Neyts J, Balzarini J, Boura E, Nencka R.. (2015) Norbornane-based nucleoside and nucleotide analogues locked in North conformation., 23 (1): [PMID:25435471] [10.1016/j.bmc.2014.11.011] |
Source
Source(1):